Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Chen (Taipei, Taiwan), L. Chien (Taipei, Taiwan), C. Tseng (Taipei, Taiwan), K. Lee (Taipei, Taiwan). Metformin predispose acute exacerbations of COPD patients with insulin-dependent diabetes mellitus>. 4027

Member's Comments

No comment yet.

Related content which might interest you: Comparison of COPD patients with and without diabetes mellitus Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 Safety profile of COPD medications in COPD patients with concomitant diabetes mellitus Source: International Congress 2017 – COPD management Year: 2017 Development of diabetes mellitus in patients with bronchial asthma Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II Year: 2008 Risk of development of diabetes mellitus in patients with bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 323s Year: 2006 The effect of diabetes mellitus on chronic obstructive pulmonary disease exacerbations Source: Eur Respir J 2001; 18: Suppl. 33, 211s Year: 2001 The evaluation of systemic inflammation in COPD patients comorbided with cardiovascular diseases or diabetes mellitus Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Impact of hyperglycaemia and comorbid diabetes mellitus on short and long-term outcome after COPD exacerbation Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Control of ventilation in patients with insulin-dependent diabetes mellitus complicated by autonomic neuropathy Source: Eur Respir J 2005; 26: Suppl. 49, 66s Year: 2005 Risks of diabetes mellitus and hyperglycaemic adverse events in patients with COPD taking inhaled corticosteroids Source: Annual Congress 2011 - Airways disease comorbidities and general aspects Year: 2011 Pulmonary microangiopathy as a possible complication in patients with diabetes mellitus Source: Eur Respir J 2004; 24: Suppl. 48, 222s Year: 2004 A study of the comorbidity of COPD and type 2 diabetes mellitus Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 COPD prevalence and severity is associated to type 2 diabetes mellitus complications and lack of glycometabolic control Source: Annual Congress 2008 - COPD and comorbidities Year: 2008 Approach to the diagnostics of early carbon metabolism disorders and diabetes mellitus 2 type in COPD patients Source: Annual Congress 2013 –COPD diagnosis Year: 2013 The conjunctival microcirculation disturbances at COPD patients in combination with diabetes mellitus type 2 and their correction by gliclazide Source: Eur Respir J 2004; 24: Suppl. 48, 61s Year: 2004 Impact of diabetes in patients with COPD Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020 The association of pulmonary fibrosis with diabetes mellitus Source: ERJ Open Res, 6 (4) 00237-2020; 10.1183/23120541.00237-2020 Year: 2020 Risks of diabetes mellitus and hyperglycaemic adverse events in patients with asthma taking inhaled corticosteroids Source: Annual Congress 2011 - Asthma management and response Year: 2011 Study of PFT‘s in patients with type 2 diabetes mellitus and diabetic neuropathy and microangiopathy Source: Annual Congress 2007 - Lung function and therapy in obstructive lung diseases Year: 2007 Hyperglycemia and diabetes mellitus as mortality risk factors in 600 COVID-19 Romanian patients Source: Virtual Congress 2021 – COVID - 19 around the globe Year: 2021